+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

From
From
From
Uterine Fibroids Pipeline Analysis Report - Product Thumbnail Image

Uterine Fibroids Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
From
Female Infertility: Epidemiology Forecast to 2033 - Product Thumbnail Image

Female Infertility: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 38 Pages
  • Global
From
IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 173 Pages
  • Global
From
Hormone Replacement Therapy Market Outlook, 2029 - Product Thumbnail Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • April 2024
  • 192 Pages
  • Global
From
From
From
From
North America IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

North America IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 76 Pages
  • North America
From
Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 68 Pages
  • Middle East, Africa
From
Asia-Pacific IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Asia-Pacific IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 83 Pages
  • Asia Pacific
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more